Lung cancer clinical trials

Explore recruiting lung cancer clinical trials.

Recruiting lung cancer studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Lung cancer trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Diagnostic Accuracy Study for OWL-EVO1 as a Lung Cancer EVOC® Probe

Hungary, Czechia

Therapeutic exploratory (Phase II) EU CTIS Study details

eXALT3: Phase 3 Randomized Study Comparing Ensartinib to Crizotinib in Anaplastic Lymphoma Kinase (ALK) Positive Non-Small Cell Lung Cancer (NSCLC) Patients

Poland, France, Spain, Czechia, Belgium, Netherlands +1 more

Therapeutic confirmatory (Phase III) EU CTIS Study details

Neoadjuvant nivolumab combination treatment in resectable non-small cell lung cancer patients: Defining optimal combinations and determinants of immunological response (NEOpredict-Lung)

Netherlands, Germany, Belgium

Therapeutic exploratory (Phase II) EU CTIS Study details

Preoperative amivantamab or amivantamab and carboplatin/pemetrexed treatment in patients with resectable non-small-cell lung cancer harboring oncogenic EGFR mutations (NEOpredict-EGFR)

Germany, Belgium, Netherlands

Therapeutic exploratory (Phase II) EU CTIS Study details

A Phase 1/2a, Open-label, Dose-finding Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of BMS-986507 (BL-B01D1) combinations in Adult Participants with Advanced Solid Tumors

Netherlands, Spain, France, Italy

Phase I and Phase II (Integrated)- Other EU CTIS Study details

Randomized, Multicenter, Phase III, Open-Label Study of Alectinib Versus Crizotinib In Treatment-Naive Anaplastic Lymphoma Kinase-Positive Advanced Non-Small Cell Lung Cancer

Poland, Spain, Portugal, Italy

Therapeutic confirmatory (Phase III) EU CTIS Study details

Lung cancer trials by city

Lung cancer in Toronto Lung cancer in Vancouver Lung cancer in Montreal Lung cancer in Calgary Lung cancer in Edmonton Lung cancer in Ottawa Lung cancer in Winnipeg Lung cancer in Quebec City Lung cancer in Hamilton Lung cancer in Kitchener Lung cancer in London Lung cancer in Halifax Lung cancer in New York Lung cancer in Los Angeles Lung cancer in Chicago Lung cancer in Houston

Other conditions

Vitiligo Hidradenitis suppurativa Rosacea Alopecia areata Endometriosis Uterine fibroids Menopause Infertility Erectile dysfunction Enlarged prostate (BPH) Breast cancer Prostate cancer Non-small cell lung cancer Colorectal cancer Pancreatic cancer Ovarian cancer Melanoma Leukemia Lymphoma Multiple myeloma Bladder cancer Kidney cancer Liver cancer Glioblastoma